 Three of the most major drugmakers with roots in China, Zai Lab Ltd NASDAQ: ZLAB, BeiGene Ltd NASDAQ: BGNE, and Hutchmed China Ltd NASDAQ: HCM, have been flagged by the SEC for failing to comply with a law governing US-listed companies. In statements responding. 